Molina Healthcare (NYSE:MOH) Price Target Raised to $372.00

Molina Healthcare (NYSE:MOH - Get Free Report) had its price target increased by equities researchers at Barclays from $359.00 to $372.00 in a research note issued on Friday, Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's target price points to a potential upside of 14.26% from the stock's current price.

Other equities research analysts also recently issued research reports about the company. Wells Fargo & Company increased their price objective on Molina Healthcare from $315.00 to $360.00 and gave the stock an "equal weight" rating in a research report on Monday, August 5th. StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, October 18th. JPMorgan Chase & Co. cut their price objective on Molina Healthcare from $420.00 to $395.00 and set an "overweight" rating for the company in a report on Wednesday, July 10th. Truist Financial lowered their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a "buy" rating on the stock in a research note on Monday, July 15th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare has a consensus rating of "Moderate Buy" and an average price target of $367.00.

Molina Healthcare Stock Performance

Shares of NYSE:MOH traded up $1.97 during trading on Friday, hitting $325.56. 1,579,517 shares of the company were exchanged, compared to its average volume of 525,746. The company has a market cap of $19.08 billion, a PE ratio of 17.84, a P/E/G ratio of 0.99 and a beta of 0.58. Molina Healthcare has a 52-week low of $272.69 and a 52-week high of $423.92. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a 50 day moving average of $335.23 and a 200 day moving average of $330.07.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, beating analysts' consensus estimates of $5.96 by $0.05. The company had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. Molina Healthcare's revenue was up 21.0% compared to the same quarter last year. During the same period last year, the business earned $5.05 earnings per share. As a group, equities research analysts predict that Molina Healthcare will post 23.5 EPS for the current year.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the company's stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares of the company's stock, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of MOH. Innealta Capital LLC purchased a new position in shares of Molina Healthcare during the 2nd quarter worth approximately $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Molina Healthcare in the 2nd quarter worth about $40,000. AM Squared Ltd bought a new position in shares of Molina Healthcare in the 2nd quarter worth about $59,000. UMB Bank n.a. lifted its position in Molina Healthcare by 96.2% during the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company's stock valued at $71,000 after acquiring an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC bought a new stake in Molina Healthcare during the first quarter worth about $151,000. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.